CAR-T therapy's cost per QALY is approximately $100,000, with consistent results across PSM, STM, and DES models. DES uniquely incorporates wait time, significantly affecting CAR-T's ...

Large-Scale Pharmacogenomics Analysis of Patients With Cancer Within the 100,000 Genomes Project Combining Whole-Genome Sequencing and Medical Records to Inform Clinical Practice SOC was dominated by ...

As an epidemiologist and physician, I’ve long been concerned about how health interventions for marginalized communities are evaluated. A new study explores that concern and offers some solutions for ...

Multicancer early detection testing results in extended life-years and reduced cancer treatment costs through earlier diagnosis, leading to a cost-effective option in cancer screening. Objectives: ...

A phase II trial of pembrolizumab plus olaparib for the treatment of patients with persistent/recurrent endometrial cancers. E7386 study 102: Global dose-expansion cohort of E7386 + lenvatinib (LEN) ...

A new analysis from the Institute for Clinical and Economic Review has found that blockbuster GLP-1 drugs from Novo Nordisk and Eli Lilly offer substantial health benefits and are a cost-effective ...

According to reports from Ukraine’s air force, Russia launched more than 19,000 missiles, including over 14,700 one-way attack drones, at targets in Ukraine from September 28, 2022, through December ...

Please provide your email address to receive an email when new articles are posted on . A ferritin threshold of 25 µg/L is cost-effective for identifying and treating women with iron deficiency.

ICER rates semaglutide and tirzepatide as cost effective vs lifestyle modifications Lilly's tirzepatide shows "promising but inconclusive" cost-effectiveness vs Novo's semaglutide Net prices of both ...